A diverse and deep product portfolio
Imugene is developing a range of animal health vaccine products to prevent important livestock diseases and enhance productivity, ultimately contributing to the safer production of protein-rich meat for human consumption and improving economic gains for the poultry and swine industries.
Our biologically-based vaccine products improve the health and welfare of pigs and poultry, reducing or eliminating the need to use antibiotics, chemicals and drugs. Imugene has a large range of products at various stages of development using Imugene’s vaccine delivery systems - the Fowl Adenovirus Vector for poultry, and the Porcine Adenoviral Vector for pigs.
|Passed commercial proof of concept||
|Passed laboratory testing||
|In laboratory development||